Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Mar 18, 2019, 07:25 ET InMed Continues to Strengthen IP Portfolio for its Biosynthesis Platform Technology

TSX: IN OTCQX: IMLFF VANCOUVER, March 18, 2019 /CNW/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a...


Mar 14, 2019, 16:05 ET Achieve Reports Financial Results for Year-End 2018 and Provides Cytisinicline Clinical Development Update

Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of...


Mar 14, 2019, 08:30 ET Advancing Clinical Trials for Leukemia Patients is Helping Improve Survival Rate

According to the Leukemia & Lymphoma Society, the world's largest voluntary health agency dedicated to blood cancer, In 2018, 60,300 people are...


Mar 13, 2019, 08:30 ET Accelerated Clinical Trials Bridging Gateway to Latest Treatments for Cancer Patients

ancer research has for years been steadily gaining ground on its way to managing, curing and even preventing the various forms of this insidious...


Mar 11, 2019, 08:00 ET FDI: Endodontics White Paper Calls for Treatment to Consider Impact on Patient Health and Well-being

GENEVA, March 11, 2019 /CNW/ - FDI World Dental Federation (FDI) released its first white paper on endodontic care today, providing an important...


Mar 11, 2019, 07:00 ET Takeda Canada announces positive results for ENTYVIO® (vedolizumab) vs. Humira® (adalimumab) in first IBD study to compare biological agents head-to-head

- ENTYVIO® superior to Humira® in achieving clinical remission and mucosal healing at week 52 in patients with moderately to severely active...


Mar 08, 2019, 08:30 ET FDA Regulations Allow Medical Devices Clinical Trials to Differ From Pharmaceutical Trials

Clinical trials are the pathway for new drugs or devices to enter the U.S. and other worldwide markets. However, not all clinical trials are the same....


Mar 07, 2019, 08:30 ET The 150th Patient in CartiHeal's Pivotal Study Was Operated on in Tel Aviv, Israel

CartiHeal, developer of proprietary implants for treating cartilage and osteochondral defects in traumatic and osteoarthritic joints, successfully...


Mar 04, 2019, 08:05 ET Breaking News for cancer patients treated with medical cannabis: Breakthrough in Panaxia clinical research to deliver medical cannabis through metered-dose inhaler

Panaxia in collaboration with the Israeli Pharmaceutical company "Rafa", has begun a clinical research of medical cannabis concentrates for...


Mar 02, 2019, 07:00 ET Bimekizumab Demonstrated Long-Term Maintenance of Complete or Almost Complete Skin Disease Resolution for Psoriasis Patients in BE ABLE 2 Extension Study

UCB, a global biopharmaceutical company, presented positive data from the Phase 2b BE ABLE extension study of bimekizumab in patients with...


Mar 01, 2019, 10:00 ET SWORD Health: AI-Powered Physical Therapy Shown to Beat Traditional Physical Therapy (in Two Studies)

Study published in Journal of Medical Internet Research confirms that SWORD's Digital Therapist not only helps patients have a quicker recovery but...


Mar 01, 2019, 07:30 ET Endo Will Showcase Late-Breaking Phase 3 CCH Data at the 2019 American Academy of Dermatology Annual Meeting

Endo International plc (NASDAQ: ENDP) today announced that it will present new data showing collagenase clostridium histolyticum (CCH) significantly...


Mar 01, 2019, 07:15 ET New Data Affirms Strength of UCB Immuno-Dermatology Portfolio

UCB, a global biopharmaceutical company, will present results from the clinical development program of the company's key pipeline molecule,...


Mar 01, 2019, 07:08 ET New Data Affirms Strength of UCB Immuno-Dermatology Portfolio

UCB, a global biopharmaceutical company, will present results from the clinical development program of the company's key pipeline molecule,...


Feb 28, 2019, 10:30 ET First Patient Enrolled in BirchBioMed's Study Investigating FS2 for the Treatment of Scars

VANCOUVER, Feb. 28, 2019 /CNW/ - BirchBioMed Inc., a clinical-stage biomedical company focused on the clinical evaluation, development and...


Feb 28, 2019, 09:30 ET Patia Study Shows That Genetics Contributes More Than Obesity to the Development of Type 2 Diabetes

DIABETESpredict will be commercialized in selected reference laboratories in the U.S. This is the world's largest study examining the contribution of ...


Feb 28, 2019, 08:00 ET Ortho Dermatologics To Present New Analyses At The American Academy Of Dermatology Annual Meeting

Ortho Dermatologics, one of the largest prescription dermatology health care businesses, and its parent company, Bausch Health Companies Inc....


Feb 27, 2019, 16:30 ET Sierra Oncology Announces Late-Breaking Oral and Poster Presentations at AACR 2019 for SRA737 and SRA141 Preclinical Data

- Late-breaking oral presentation to report preclinical mechanistic and efficacy data for immunotherapy combined with SRA737 + LDG, its Chk1...


Feb 27, 2019, 08:00 ET Ortho RTi Confirms Timeline to Initiate Human Clinical Program After Meeting with the FDA

IND can be submitted in parallel with completion of pivotal study on Ortho-R for Rotator Cuff repair Product characterization, safety and toxicology...


Feb 26, 2019, 08:00 ET Reliq Health Technologies Announces New Trial with Community HealthNet Health Centers, Indiana

HAMILTON, ON, Feb. 26, 2019 /CNW/ - Reliq Health Technologies Inc. (TSXV:RHT or OTCQB:RQHTF) ("Reliq" or the "Company"), a technology company that...


Feb 25, 2019, 10:08 ET Texas Cardiac Arrhythmia Institute at St. David's Medical Center enrolling patients to test stroke-reducing device

The Texas Cardiac Arrhythmia Institute at St. David's Medical Center recently began enrolling patients to participate in the DIAMOND-AF II clinical...


Feb 22, 2019, 07:30 ET Paladin Labs Inc. Announces Approval of Envarsus PA™ (tacrolimus prolonged-release tablets) in Canada

Paladin Labs Inc. and Endo Ventures Limited, subsidiaries of Endo International plc (NASDAQ: ENDP), today announced Health Canada's approval of...


Feb 21, 2019, 12:09 ET AbbVie reaches an agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for its hepatitis C treatment MAVIRET™

Ontario will be the first province to reimburse MAVIRET as of February 28, 2019 MAVIRET is the first and only 8-week, pan-genotypic treatment for...


Feb 19, 2019, 14:17 ET Senzer's ISO Certification: A First for the Pharmaceutical Cannabinoid Sector

In what is believed to be the first-ever ISO certification for the Design and Development of a medical device to deliver pharmaceutical-grade...


Feb 19, 2019, 07:00 ET Bausch Health Acquires Eton Pharmaceuticals' EM-100 Investigational Eye Drop For The Treatment Of Itchy Eyes Associated With Allergies

Bausch Health Companies Inc. (NYSE/TSX: BHC) and Bausch + Lomb, its wholly owned subsidiary and a leading global eye health company, and Eton...